Breast cancer study

October 1, 2014 1:36 AM

17 0

Rochester, N.Y. - Perjeta is a new drug is extending the lives of some women with stage four breast cancer by more than one year.

When combined with the benefits of a second drug, patients are living as long as four and a half years more.

Read more

To category page